Ocular surface disease innovation creating infrastructure — pterygium drugs providing conjunctival growth suppression managing pterygium enabling disease control, establishing pterygium therapy as essential ophthalmology infrastructure, with the Pterygium Drug Market experiencing expansion driven by pterygium prevalence, progression prevention emphasis, and therapeutic advancement...